| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |